144 related articles for article (PubMed ID: 3995301)
1. Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex.
Quirion R; Richard J; Dam TV
Brain Res; 1985 May; 333(2):345-9. PubMed ID: 3995301
[TBL] [Abstract][Full Text] [Related]
2. Cortical serotonin receptor subtypes after lesion of ascending cholinergic neurones in rat.
Cross AJ; Deakin JF
Neurosci Lett; 1985 Oct; 60(3):261-5. PubMed ID: 4069435
[TBL] [Abstract][Full Text] [Related]
3. Functional and neurochemical cortical cholinergic impairment following neurotoxic lesions of the nucleus basalis magnocellularis in the rat.
el-Defrawy SR; Coloma F; Jhamandas K; Boegman RJ; Beninger RJ; Wirsching BA
Neurobiol Aging; 1985; 6(4):325-30. PubMed ID: 2935744
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
Sparks DL; Markesbery WR; Slevin JT
Ann Neurol; 1986 Jun; 19(6):602-4. PubMed ID: 2425718
[TBL] [Abstract][Full Text] [Related]
5. Are the neurochemical and behavioral changes induced by lesions of the nucleus basalis in the rat a model of Alzheimer's disease?
Pepeu G; Casamenti F; Pedata F; Cosi C; Pepeu IM
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):541-51. PubMed ID: 2879319
[TBL] [Abstract][Full Text] [Related]
6. Deoxyglucose uptake and choline acetyltransferase activity in cerebral cortex following lesions of the nucleus basalis magnocellularis.
Lamarca MV; Fibiger HC
Brain Res; 1984 Jul; 307(1-2):366-9. PubMed ID: 6540615
[TBL] [Abstract][Full Text] [Related]
7. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI
Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399
[TBL] [Abstract][Full Text] [Related]
8. Specific toxic effects of ethylcholine nitrogen mustard on cholinergic neurons of the nucleus basalis of Meynert.
Kozlowski MR; Arbogast RE
Brain Res; 1986 Apr; 372(1):45-54. PubMed ID: 3708359
[TBL] [Abstract][Full Text] [Related]
9. Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis.
Lapchak PA; Araujo DM; Pasinetti G; Hefti F
Brain Res; 1993 Jun; 613(2):239-46. PubMed ID: 8186970
[TBL] [Abstract][Full Text] [Related]
10. Effect of lesions of the nucleus basalis magnocellularis and of treatment with posatirelin on cholinergic neurotransmission enzymes in the rat cerebral cortex.
Sabbatini M; Coppi G; Maggioni A; Olgiati V; Panocka I; Amenta F
Mech Ageing Dev; 1998 Aug; 104(2):183-94. PubMed ID: 9792196
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.
Hu L; Côté SL; Cuello AC
Exp Neurol; 1997 Jan; 143(1):162-71. PubMed ID: 9000455
[TBL] [Abstract][Full Text] [Related]
13. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Whitehouse PJ
Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
[No Abstract] [Full Text] [Related]
14. Maintenance of cortical somatostatin and monoamine levels in the rat does not require intact cholinergic innervation.
Fine A; Pittaway K; de Quidt M; Czudek C; Reynolds GP
Brain Res; 1987 Mar; 406(1-2):326-9. PubMed ID: 2436718
[TBL] [Abstract][Full Text] [Related]
15. Recovery of neocortical choline acetyltransferase activity following ibotenic acid injection into the nucleus basalis of Meynert in rats.
Wenk GL; Olton DS
Brain Res; 1984 Feb; 293(1):184-6. PubMed ID: 6704718
[TBL] [Abstract][Full Text] [Related]
16. Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies.
Bartus RT; Flicker C; Dean RL; Pontecorvo M; Figueiredo JC; Fisher SK
Pharmacol Biochem Behav; 1985 Jul; 23(1):125-35. PubMed ID: 4041042
[TBL] [Abstract][Full Text] [Related]
17. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1.
Casamenti F; Milan F; Pepeu G
Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer plaques and cortical cholinergic innervation.
Mesulam MM
Neuroscience; 1986; 17(1):275-6. PubMed ID: 3960313
[No Abstract] [Full Text] [Related]
19. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions.
Rossner S; Schliebs R; Bigl V
Brain Res; 1994 Dec; 668(1-2):85-99. PubMed ID: 7704621
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the nucleus basalis of Meynert increases acetylcholine release in the cerebral cortex in rats.
Kurosawa M; Sato A; Sato Y
Neurosci Lett; 1989 Mar; 98(1):45-50. PubMed ID: 2565563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
